-
The Modified Shuyu Pill Inhibits the Formation of Pre-Metastatic Niches in Triple-Negative Breast Cancer by Reducing the Number of Myeloid-Derived Suppressor Cells (MDSCs) via the JAK2/STAT3 Pathway
10 Dec 2025 18:55 GMT
… treatments, particularly immunotherapies.6 Therefore, exploring new strategies and drugs … purchased from Yangzijiang Pharmaceutical Group Co.
… by Shanghai Shenggong Biotechnology Co., Ltd.) … medicine and biomarker-driven approaches to counteract Trichostatin …
-
Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity
02 Sep 2025 16:45 GMT
… of modern medicine and biotechnology, the research … pharmaceuticals or possible therapeutic targets for CTIC treatment … trials are needed to further explore.
Chemotherapy Targeted Drugs … medicine and biomarker-driven approaches to counteract Trichostatin …
-
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis
31 Jan 2024 17:12 GMT
… . Onychomycosis: a significant medical disorder. J Am Acad … A New Antifungal Antibiotic, Trichostatin. J Antibiot (Tokyo). … VTR-297 in the treatment of onychomycosis. Therefore, … -pharmaceuticals-receives-fda-approval-to-proceed-with-investigational-new-drug …
-
Research Progress of NK Cells in Glioblastoma Treatment
17 Jan 2025 13:59 GMT
… undergoing clinical trials for GBM treatment (CAR2BRAIN; NCT0338978 … continuous progress of biotechnology, we firmly believe … Doctor Foundation of the Second Affiliated Hospital of Xi’an Medical … histone deacetylase inhibitor trichostatin a promotes apoptosis …
-
The Advances in the Development of Epigenetic Modifications Therapeutic Drugs Delivery Systems
18 Oct 2024 12:49 GMT
… effectiveness of epigenetic medications. By improving permeability … trials were isohydroxamic acid analogs.69 The FDA-approved drug … belinostat [PXD101], and trichostatin A [TSA]) were … trial data for nano-based epigenetic drugs in breast cancer treatment …
-
Molecular Insights into Phytochemicals Mediated Epigenetic Regulation in Preclinical Models of Breast Cancer
27 Nov 2025 10:27 GMT
… the histone deacetylase inhibitor Trichostatin A (TSA) can … used as chemotherapeutic drugs for cancer treatment.149,150 A … limit their potential as medicinal drug or formulation. Many … challenges, and future perspectives. Pharmaceuticals. 2025;18(2):207. …
-
HDAC Inhibitor Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
08 Jan 2024 18:00 GMT
… HDAC inhibitor drugs to improve the treatment landscape. … acids (e.g., trichostatin A, vorinostat), cyclic … Tracon Pharmaceuticals Inc., Celgene, MedImmune, Hangzhou Sumgen Biotech, Lepu … , Jiangsu Hengrui Medicine Co., MaxiNovel Pharmaceuticals, among others …
-
HRT Financial LP Has $396,000 Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
06 Jun 2023 10:25 GMT
… of therapies for high unmet medical needs. The firm intends to … portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051.
Featured Stories
Want … analysts' ratings for Vanda Pharmaceuticals and related companies with MarketBeat …
-
Vanda Pharmaceuticals (NASDAQ:VNDA) Downgraded by StockNews.com to “Buy”
02 Jun 2023 07:52 GMT
… institutional investors.
About Vanda Pharmaceuticals
(Get Rating)
Vanda Pharmaceuticals, Inc engages in … of therapies for high unmet medical needs. The firm intends to … , Trichostatin, and AQW051.
See Also
Receive News & Ratings for Vanda Pharmaceuticals …
-
Fisher Asset Management LLC Boosts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
29 Apr 2023 12:15 GMT
… company insiders.
About Vanda Pharmaceuticals
(Get Rating)
Vanda Pharmaceuticals, Inc engages in … of therapies for high unmet medical needs. The firm intends to … , Trichostatin, and AQW051.
See Also
Receive News & Ratings for Vanda Pharmaceuticals …
About
© 1995-2025